Menu

Search
Close this search box.

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages TG Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – TGTX

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of TG Therapeutics, Inc. (NASDAQ: TGTX) between January 15, 2020 and May 31, 2022, both dates inclusive (the “Class Period”), of the important September 16, 2022 lead

Read More

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages MINISO Group Holding Limited Investors to Inquire About Securities Class Action Investigation – MNSO

NEW YORK, Aug. 08, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of MINISO Group Holding Limited (NYSE: MNSO) resulting from allegations that MINISO may have issued materially misleading business information to the investing

Read More

Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results DREAM enrollment complete, 12-month clinical data expected in fall of 2023 Mont-Saint-Guibert, Belgium – August 8, 2022, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company

Read More